newsfilter
← Latest News
GlobeNewswire·

VERAXA Biotech to Launch AI-enabled Drug Discovery Collaboration with Ardigen to Support Growing BiTAC® Pipeline

ZURICH, SWITZERLAND – July 13, 2026 -- VERAXA Biotech AG (NASDAQ:VRXA, "VERAXA")), an emerging leader in designing novel cancer therapies, today announced a collaboration with Ardigen S.A., an AI-driven